SOLIGENIX, INC. Grants Receivable, Current
SOLIGENIX, INC. (SNGX) had Grants Receivable, Current of $117.03 thousand as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Notes › Nontrade Receivables › Nontrade Receivables, Current
us-gaap:GrantsReceivableCurrent · last filed 2024-05-10
- 2024-03-31: Grants Receivable, Current $117.03K.
- 2023-09-30: Grants Receivable, Current $66.05K.
- 2023-06-30: Grants Receivable, Current $113.76K.
- 2023-03-31: Grants Receivable, Current $218.01K.
| Period end | Grants Receivable, Current |
|---|---|
| 2024-03-31 | $117.03K 10-Q · filed 2024-05-10 |
| 2023-09-30 | $66.05K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $113.76K 10-Q · filed 2023-08-21 |
| 2023-03-31 | $218.01K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $115.13K 10-K · filed 2024-03-15 |
| 2022-09-30 | $130.74K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $321.78K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $123.69K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $138.89K 10-K · filed 2023-03-31 |
| 2021-09-30 | $44.18K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $117.68K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $161.72K 10-Q · filed 2021-05-18 |
| 2020-12-31 | $203.77K 10-K · filed 2022-03-29 |
| 2020-09-30 | $394.40K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $334.79K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $841.37K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $1.02M 10-K · filed 2021-03-30 |
| 2019-09-30 | $869.30K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.68M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $1.11M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $1.20M 10-K · filed 2020-03-30 |
| 2018-09-30 | $998.61K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $1.53M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $826.99K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $926.25K 10-K · filed 2019-03-26 |
| 2017-09-30 | $634.87K 10-Q · filed 2017-11-06 |
| 2017-06-30 | $714.89K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $993.49K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $1.21M 10-K · filed 2018-03-15 |
| 2016-09-30 | $1.70M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $1.81M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $1.02M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $1.99M 10-K · filed 2017-03-27 |
| 2015-09-30 | $1.86M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $733.57K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $345.42K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $794.77K 10-K · filed 2016-03-24 |
| 2014-09-30 | $1.34M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $465.06K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $694.35K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $867.09K 10-K · filed 2015-03-25 |
| 2013-09-30 | $161.84K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $190.11K 10-Q · filed 2013-08-12 |
| 2013-03-31 | $656.85K 10-Q · filed 2013-05-03 |
| 2012-12-31 | $339.31K 10-K · filed 2014-03-26 |
| 2012-09-30 | $238.57K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $239.60K 10-Q · filed 2012-08-10 |
| 2012-03-31 | $324.40K 10-Q · filed 2012-05-14 |
| 2011-12-31 | $362.47K 10-K · filed 2013-02-26 |
| 2011-09-30 | $297.85K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $336.56K 10-Q · filed 2011-08-12 |
| 2010-12-31 | $120.79K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |